Quote:
Originally Posted by Dr. Smith
It looks to me like a study of (or on) Sativex®
|
The main issue I find with Sativex is the cost. I believe it will be approved for NP in the US but it will make Lyrica look cheap and insurance will likely deny coverage. There are other pharma companies jumping on the CBD bandwagon and they too will eventually gain FDA approval and a hefty price tag.
Six months ago out of extreme pain, frustration and desperation, I decided to conduct my own study, on myself to see if I could obtain relief with cannabis-based products and I am very happy I did.